Despite renewed interest in the role of PKM2 in cancer metabolism, lack of small molecule inhibitors that effectively target PKM2, but not mitochondria, has posed constrain in elucidating the contribution of PKM2 to overall cancer metabolism. This evidence concerns the gene PKM and cancer.